Volver a Agenda
Session Chair(s)
Rebecca Daniels Kush, PHD
President, Catalysis; Chief Scientific Officer
Elligo Health Research, United States
Learning Objective : Discuss the importance of data standards and their implementation to improve global clinical research processes and knowledge gained from research data; Identify how CFAST will support the FDA in its efforts to improve the quality and speed in reviews of regulatory submissions for new therapies.
Speaker(s)
Panelist
David C. Jordan, PHD, MSC
Retired, United States
Panelist
Brian Harvey, MD
Global Liver Institute, United States
Executive Vice President and Board Member
Panelist
Ron Fitzmartin, PHD, MBA
Decision Analytics, United States
Principal Consultant
¿Tiene una cuenta?